Investors Relations
Historical Financial Snapshot (Consolidated)
Quarter 1
Quarterly results
Quarterly results
Investor Presentation
Investor Presentation
Earning conference call recording Q1 FY26
Play Recording
Earning conference call transcript
View PDF
Intimation of the scheduled earnings call
View PDF
Outcome of the earnings call of the quarter ended
View PDF
Quarter 2
Quarterly results
Investor Presentation
Earning conference call recording Q1 FY26
Earning conference call transcript
Intimation of the scheduled earnings call
Outcome of the earnings call of the quarter ended
Quarter 3
Quarterly results
Quarterly results
Investor Presentation
Investor Presentation
Earning conference call recording Q1 FY26
Play Recording
Earning conference call transcript
View PDF
Intimation of the scheduled earnings call
View PDF
Outcome of the earnings call of the quarter ended
View PDF
Quarter 4
Quarterly results
Quarterly results
Investor Presentation
Investor Presentation
Earning conference call recording Q1 FY26
Play Recording
Earning conference call transcript
View PDF
Intimation of the scheduled earnings call
View PDF
Outcome of the earnings call of the quarter ended
View PDF
Quarterly Results
Investor Presentations
Press Release
| Financial Year | April – June Q1 | July – September Q2 | October – December Q3 | January – March Q4 | Others |
|---|---|---|---|---|---|
| FY 2026-2027 | 📄 Intimation of Schedule of Analyst-Institutional Investor Meetings | ||||
| FY 2025-2026 | – | 📄 | 📄📄 | 📄Intimation for Investor Meet 📄 Intimation for Earnings Call Q4 FY26 | – |
| Financial Year | Annual Report (PDF) | Annual Report Video | BRSR / Sustainability | Others |
|---|---|---|---|---|
| FY 2024-2025 | 📄 | – | – | – |
| Financial Year | Annual Return |
|---|---|
| FY 2024-2025 | 📄 |
| Financial Year | Sudeep Nutrition Private Limited | Sudeep Advanced Materials Private Limited | Sudeep Pharma USA Inc | Sudeep Pharma B.V. |
|---|---|---|---|---|
| FY 2024-2025 | Annual Report | Financial Statement | Financial Statement | Financial Statement |
Meetings
Memorandum of Association and Articles of Association
Other Documents and Details
Policies
| Name | Download |
|---|---|
| Code of Conduct | 📄 |
| Policy – Familiarisation Programs for Independent Directors | 📄 |
| Corporate Social Responsibility Policy | 📄 |
| Human Rights Policy | 📄 |
| Prevention of Sexual Harrassment Policy at Workplace | 📄 |
| Nomination and Remuneration Policy | 📄 |
| Vigil Mechanism Policy | 📄 |
| Dividend Policy | 📄 |
| Materiality Policy | 📄 |
| Determination of Materiality of Event Policy | 📄 |
| Materiality of Related Party Transactions | 📄 |
| Employee Stock Option Scheme 2025 | 📄 |
| Records and Archive Management Policy | 📄 |
| Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading | 📄 |
Reports and Filings with Stock Exchange
Meetings
| Financial Year | Name | Download |
|---|---|---|
| FY 2025-2026 |
| Financial Year | Name | Download |
|---|---|---|
| FY 2025-2026 |
| Financial Year | Name | Download |
|---|---|---|
| FY 2025-2026 |
Memorandum of Association and Articles of Association
Other Documents and Details
Policies
| Name | Download |
|---|---|
| Code of Conduct | 📄 |
| Policy – Familiarisation Programs for Independent Directors | 📄 |
| Corporate Social Responsibility Policy | 📄 |
| Human Rights Policy | 📄 |
| Prevention of Sexual Harrassment Policy at Workplace | 📄 |
| Nomination and Remuneration Policy | 📄 |
| Vigil Mechanism Policy | 📄 |
| Dividend Policy | 📄 |
| Materiality Policy | 📄 |
| Determination of Materiality of Event Policy | 📄 |
| Materiality of Related Party Transactions | 📄 |
| Employee Stock Option Scheme 2025 | 📄 |
| Records and Archive Management Policy | 📄 |
| Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading | 📄 |
Reports and Filings with Stock Exchange
Disclosure under Regulation 46 of SEBI (LODR) Regulation, 2015
| Title | Link |
|---|---|
| Details of Business | View |
| Financial Results | View |
| Investors Presentation | View |
| Annual Report | View |
| MOA & AOA | View |
| Notice of Board Meeting | View |
| Outcome of Board Meeting | View |
| Transcript of Post Earnings/Investors or Quarterly Calls | View |
| Audio/Video Recording of Schedule of Analyst/Institutional Investors Meet | View |
| Intimation of Schedule of Analyst/Institutional Investors Meet | View |
| Criteria of making payments to non-executive directors | View |
| Code of conduct of board of directors and senior management personnel; | View |
| Policy on Dividend Distribution | View |
| Investor Contact for Grievance Redressal and Other Relevant Details | View |
| Separate audited financial statements of each subsidiary of the listed entity •Indian Companies •Foreign Companies | View |
| Newspaper Publication / Press Release | View |
| Annual Return under Section 92 of the Companies Act 2013 | View |
| Secretarial Compliance Report under Regulation 24A | View |
| Shareholding Pattern | View |
| Brief Profile of Directors | View |
| Terms and conditions of appointment of independent directors | View |
| Composition of Committees | View |
| Vigil mechanism/ Whistle Blower policy | View |
| Policy on dealing with related party transactions; | View |
| Policy for Determining Material Subsidiaries | View |
| Policy for determination of materiality of events or information under Regulation 30 | View |
| Disclosure of Contact Details of Key Managerial Personnel | View |
| Familiarisation Programme for Independent Directors | View |
| New Name and the old Name of the listed entity for a continuous period of one year, from the date of the last name change. | Change of Name from 'Private Limited' to 'Limited' |
| Submission Under Regulation 30 | View |
| Details of Agreements entered into with the media Companies & or Associates etc. | Not Applicable |
| All Credit Rating obtained by the entity | Not Applicable |
Investor Information
Sudeep Pharma Limited
Address: 601-602, Sears 2, East Wing, Gotri-Sevasi Road, Sevasi, Vadodara, Gujarat, India – 391101
CIN: L24231GJ1989PLC013141
Company Secretary and Compliance Officer:
Ms. Dimple Mehta
Tel. (Direct): +91 2652840656 / 329 1354
E-Mail:
cs*******@su*********.com
Investor Relations:
Tel. (Direct): +91 2652840656 / 329 1354
E-Mail:
in*******@su*********.com
Registrar:
MUFG Intime India Private Limited (Formerly Link Intime India Private Limited)
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai 400 083
Maharashtra, India
Tel: +91 81 0811 4949
Investor Grievance ID: su**************@in.com
Website: www.in.mpms.mufg.com
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058

